A 38-year-old woman with diabetes and hypertension presents with eruptive xanthomas on her buttocks and elbows. Fasting lipid profile: total cholesterol 320 mg/dL, LDL-C 140 mg/dL, HDL-C 28 mg/dL, triglycerides 1200 mg/dL. Serum is visibly lipemic. Which investigation is most appropriate to confirm the underlying lipid disorder?

Explanation

## Clinical Presentation Analysis The patient presents with: - Eruptive xanthomas (pathognomonic for severe hypertriglyceridemia) - Visibly lipemic serum (indicates triglycerides >1000 mg/dL) - Severe hypertriglyceridemia (1200 mg/dL) - Low HDL-C (28 mg/dL) - Relatively modest LDL-C elevation (140 mg/dL) - Diabetes and hypertension (secondary causes of hypertriglyceridemia) This clinical picture is consistent with **Type IV or Type V hyperlipoproteinemia** (elevated VLDL ± chylomicrons). ## Why Fasting Serum Triglyceride and Lipoprotein Electrophoresis? **Key Point:** Fasting serum triglyceride level is the first-line confirmatory test for severe hypertriglyceridemia. Lipoprotein electrophoresis identifies the lipoprotein pattern (Type IV: elevated VLDL; Type V: elevated VLDL + chylomicrons) and distinguishes primary from secondary causes. **High-Yield:** The combination of: 1. **Fasting triglyceride >1000 mg/dL** confirms severe hypertriglyceridemia 2. **Lipoprotein electrophoresis** shows the lipoprotein phenotype: - Type IV: VLDL band prominent (primary hypertriglyceridemia) - Type V: VLDL + chylomicron bands (suggests lipoprotein lipase deficiency or ApoC-II deficiency) This phenotypic classification guides management and risk assessment for acute pancreatitis. ## Differential Investigations | Investigation | Role | Why Not Here | |---|---|---| | ApoC-II level | Identifies ApoC-II deficiency (rare cause of Type V) | Measured only if Type V pattern confirmed on electrophoresis; not first-line | | Lipoprotein lipase activity | Detects LPL deficiency (Type I or V) | Specialized test; not routine; requires electrophoresis first | | **Fasting triglyceride + electrophoresis** | **Confirms diagnosis and identifies lipoprotein pattern** | **First-line confirmatory approach** | | APOC2/LPL gene testing | Identifies genetic defects in rare primary forms | Reserved for atypical presentations or family history; not first-line | **Clinical Pearl:** Eruptive xanthomas are lipid-laden macrophage infiltrates in skin and appear when triglycerides exceed ~1000 mg/dL. They regress with triglyceride normalization, unlike tendon xanthomas (which indicate chronic LDL elevation). ## Diagnostic Algorithm for Severe Hypertriglyceridemia ```mermaid flowchart TD A["Eruptive xanthomas + Lipemic serum"]:::outcome --> B["Fasting triglycerides"]:::action B --> C{"Triglycerides > 1000?"}:::decision C -->|Yes| D["Lipoprotein electrophoresis"]:::action D --> E{"Pattern?"}:::decision E -->|"Type IV"| F["Primary VLDL overproduction"]:::outcome E -->|"Type V"| G["Check ApoC-II, LPL activity"]:::action G --> H{"Deficiency?"}:::decision H -->|"ApoC-II low"| I["ApoC-II deficiency"]:::outcome H -->|"LPL low"| J["Lipoprotein lipase deficiency"]:::outcome H -->|"Both normal"| K["Secondary HTG (diabetes, alcohol)"]:::outcome ``` **Mnemonic: TRIG-ELECT** — TRIGlyceride level + ELECTrophoresis = first-line confirmation of severe hypertriglyceridemia phenotype.